By order No. 195-НҚ dated 04.04.2025, the Committee for Medical and Pharmaceutical Control revokes the registration certificate of the medicinal product VOLTAREN®, 50 mg, enteric-coated tablets, RK-LS-5№013520, manufacturer Novartis Urunleri, Turkey, holder of the registration certificate Novartis Pharma AG, Switzerland.
Basis: letter from the branch of Novartis Pharma Services AG in the Republic of Kazakhstan No. 34 dated March 17, 2025.
The order was signed by the Acting Chairman of the Committee for Medical and Pharmaceutical Control of the Ministry of Health of the Republic of Kazakhstan A. Kenzhekhanova.
Источник: Казахстанский Фармацевтический Вестник, pharmnews.kz
Basis: letter from the branch of Novartis Pharma Services AG in the Republic of Kazakhstan No. 34 dated March 17, 2025.
The order was signed by the Acting Chairman of the Committee for Medical and Pharmaceutical Control of the Ministry of Health of the Republic of Kazakhstan A. Kenzhekhanova.
Источник: Казахстанский Фармацевтический Вестник, pharmnews.kz
